MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation suspension for ...
Three of Anthropic’s Claude Desktop extensions were vulnerable to command injection – flaws that have now been fixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback